Designing non-peptide peptidomimetics in the 21st century: inhibitors targeting conformational ensembles.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2002-01-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM010425BPMID 11806706
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New renin inhibitors containing novel analogues of statine.

  2009cited by this paper
• Potent in vivo inhibitors of rat renin: analogues of human and rat angiotensinogen sequences containing different classes of pseudodipeptides at the scissile site.

  2009cited by this paper
• Folding funnels and conformational transitions via hinge-bending motions

  2007cited by this paper
• The mechanism of the catalytic action of pepsin and related acid proteinases.

  2006cited by this paper
• Design and synthesis of unsymmetrical peptidyl urea inhibitors of aspartic peptidases.

  2001cited by this paper
• Ab initio molecular dynamics-based assignment of the protonation state of pepstatin A/HIV-1 protease cleavage site.

  2001cited by this paper
• DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases

  2001cited by this paper
• Conformation of a peptide ligand bound to its G-protein coupled receptor

  2001cited by this paper
• Aspartic protease inhibitors designed from computer-generated templates bind as predicted.

  2001cited by this paper
• Piperidine renin inhibitors: from leads to drug candidates.

  2001cited by this paper
• Two-state allosteric behavior in a single-domain signaling protein.

  2001cited by this paper
• Approaches to solving the rigid receptor problem by identifying a minimal set of flexible residues during ligand docking.

  2001cited by this paper
• From peptides to non-peptide peptidomimetics: design and synthesis of new piperidine inhibitors of aspartic peptidases.

  2001cited by this paper
• Follow the protons: a low-barrier hydrogen bond unifies the mechanisms of the aspartic proteases.

  2001cited by this paper
• Protease inhibitors: current status and future prospects.

  2000cited by this paper
• Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin.

  2000cited by this paper
• Conformational selection of inhibitors and substrates by proteolytic enzymes: implications for drug design and polypeptide processing.

  2000cited by this paper
• Conformational flexibility of the catalytic Asp dyad in HIV‐1 protease: An ab initio study on the free enzyme

  2000cited by this paper
• Accommodating protein flexibility in computational drug design.

  2000cited by this paper
• Approaches to the design of effective HIV-1 protease inhibitors.

  2000cited by this paper
• Molecular recognition of macrocyclic peptidomimetic inhibitors by HIV-1 protease.

  1999cited by this paper
• Folding funnels and binding mechanisms.

  1999cited by this paper
• Substituted piperidines--highly potent renin inhibitors due to induced fit adaptation of the active site.

  1999cited by this paper
• Folding funnels, binding funnels, and protein function

  1999cited by this paper
• Piperidine-renin inhibitors compounds with improved physicochemical properties.

  1999cited by this paper
• Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases?

  1999cited by this paper
• A 2.3 A resolution structure of chymosin complexed with a reduced bond inhibitor shows that the active site beta-hairpin flap is rearranged when compared with the native crystal structure.

  1998cited by this paper
• Synthesis of novel cyclic protease inhibitors using Grubbs olefin metathesis.

  1998cited by this paper
• Peptidomimetic design.

  1998cited by this paper
• Tipranavir (PNU-140690): a potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide class.

  1998cited by this paper
• Transpeptidation by Porcine Pepsin Catalyzed by a Noncovalent Intermediate Unique to Its Iso-mechanism*

  1998cited by this paper
• Molecular docking to ensembles of protein structures.

  1997cited by this paper
• 4-hydroxy-5,6-dihydropyrones. 2. Potent non-peptide inhibitors of HIV protease.

  1997cited by this paper
• Modern computational chemistry and drug discovery: structure generating programs.

  1997cited by this paper
• The art and practice of structure‐based drug design: A molecular modeling perspective

  1996cited by this paper
• Cyclic HIV protease inhibitors: synthesis, conformational analysis, P2/P2' structure-activity relationship, and molecular recognition of cyclic ureas.

  1996cited by this paper
• Safety and activity of saquinavir in HIV infection.

  1995cited by this paper
• A hot spot of binding energy in a hormone-receptor interface

  1995cited by this paper
• GREEN: A program package for docking studies in rational drug design

  1994cited by this paper
• Solvent isotope effects on the onset of inhibition of porcine pepsin by pepstatin.

  1994cited by this paper
• Structure-based design of HIV protease inhibitors: 4-hydroxycoumarins and 4-hydroxy-2-pyrones as non-peptidic inhibitors.

  1994cited by this paper
• In search of ideal antihypertensive drugs: progress in five decades.

  1994cited by this paper
• CAVEAT: A program to facilitate the design of organic molecules

  1994cited by this paper
• Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors.

  1994cited by this paper
• HOOK: A program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macromolecule binding site

  1994cited by this paper
• Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design.

  1994cited by this paper
• GenStar: A method for de novo drug design

  1993cited by this paper
• FOUNDATION: A program to retrieve all possible structures containing a user-defined minimum number of matching query elements from three-dimensional databases

  1993cited by this paper
• Concepts and progress in the development of peptide mimetics.

  1993cited by this paper
• GroupBuild: a fragment-based method for de novo drug design.

  1993cited by this paper
• The NEWLEAD program: a new method for the design of candidate structures from pharmacophoric hypotheses.

  1993cited by this paper
• Peptidomimetics derived from natural products

  1993cited by this paper
• Structure of a pepsin/renin inhibitor complex reveals a novel crystal packing induced by minor chemical alterations in the inhibitor.

  1992cited by this paper
• Crystallographic analysis of transition state mimics bound to penicillopepsin: difluorostatine- and difluorostatone-containing peptides.

  1992cited by this paper
• Domain flexibility in aspartic proteinases

  1992cited by this paper
• LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads

  1992cited by this paper
• The computer program LUDI: A new method for the de novo design of enzyme inhibitors

  1992cited by this paper
• A novel method for the modelling of peptide ligands to their receptors.

  1991cited by this paper
• The active site of aspartic proteinases

  1991cited by this paper
• Novel binding mode of highly potent HIV-proteinase inhibitors incorporating the (R)-hydroxyethylamine isostere.

  1991cited by this paper
• Effect of hydroxyl group configuration in hydroxyethylamine dipeptide isosteres on HIV protease inhibition. Evidence for multiple binding modes.

  1991cited by this paper
• Human immunodeficiency virus-1 protease. 2. Use of pH rate studies and solvent kinetic isotope effects to elucidate details of chemical mechanism.

  1991cited by this paper
• X-ray analyses of aspartic proteinases. IV. Structure and refinement at 2.2 A resolution of bovine chymosin.

  1991cited by this paper
• Computer design of bioactive molecules: A method for receptor‐based de novo ligand design

  1991cited by this paper
• X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor.

  1990cited by this paper
• The three‐dimensional structure of recombinant bovine chymosin at 2.3 Å resolution

  1990cited by this paper
• Revised 2.3 Å structure of porcine pepsin: Evidence for a flexible subdomain

  1990cited by this paper
• Renin inhibitors.

  1990cited by this paper
• Hydroxyethylamine analogues of the p17/p24 substrate cleavage site are tight-binding inhibitors of HIV protease.

  1990cited by this paper
• Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution.

  1989cited by this paper
• High‐resolution X‐ray diffraction study of the complex between endothiapepsin and an oligopeptide inhibitor: the analysis of the inhibitor binding and description of the rigid body shift in the enzyme.

  1989cited by this paper
• Engineering enzyme specificity by "substrate-assisted catalysis".

  1987cited by this paper
• Binding of a reduced peptide inhibitor to the aspartic proteinase from Rhizopus chinensis: implications for a mechanism of action.

  1987cited by this paper
• Inhibition of aspartic proteases by pepstatin and 3-methylstatine derivatives of pepstatin. Evidence for collected-substrate enzyme inhibition.

  1985cited by this paper
• Pepstatin-derived inhibitors of aspartic proteinases. A close look at an apparent transition-state analogue inhibitor.

  1985cited by this paper
• A computational procedure for determining energetically favorable binding sites on biologically important macromolecules.

  1985cited by this paper
• Design of peptide derived amino alcohols as transition-state analog inhibitors of angiotensin converting enzyme.

  1985cited by this paper
• Synthesis of analogues of pepstatin. Effect of structure in subsites P1', P2', and P2 on inhibition of porcine pepsin.

  1983cited by this paper
• Structure and refinement of penicillopepsin at 1.8 A resolution.

  1983cited by this paper
• Conformational flexibility in the active sites of aspartyl proteinases revealed by a pepstatin fragment binding to penicillopepsin.

  1982cited by this paper
• Three-dimensional structure of the complex of the Rhizopus chinensis carboxyl proteinase and pepstatin at 2.5-A resolution.

  1982cited by this paper
• Mechanism of acid protease catalysis based on the crystal structure of penicillopepsin

  1977cited by this paper
• Mode of inhibition of acid proteases by pepstatin.

  1976cited by this paper
• Mechanism of inhibition of pepsin by pepstatin.

  1972cited by this paper
• Pepstatin, a new pepsin inhibitor produced by Actinomycetes.

  1970cited by this paper
• FORMATION OF THE SECONDARY AND TERTIARY STRUCTURE OF ENZYMES.

  1964cited by this paper
• Application of a Theory of Enzyme Specificity to Protein Synthesis.

  1958cited by this paper
• The conformation of the steroid nucleus

  1950cited by this paper

• Peptides and peptidоmimetics in neuropharmacology (Review)

  2023cites this paper
• Catalytic Asymmetric Hydrogenation of Tetrasubstituted Unsaturated Lactams: An Efficient Approach to Enantioenriched 3,4-Disubstituted Piperidines.

  2022cites this paper
• Nanoparticle assembled structures for matter assays in human flowing systems

  2022cites this paper
• Protocol for iterative optimization of modified peptides bound to protein targets

  2022cites this paper
• Multicomponent Reactions of Isocyanides for the Preparation of Low Molecular Weight Gelators: Preliminary Studies

  2021cites this paper
• Insights Into the Regulation of Gynecological Inflammation-Mediated Malignancy by Metalloproteinases

  2021cites this paper
• What’s in a name? From “fluctuation fit” to “conformational selection”: rediscovery of a concept

  2021cites this paper
• Amide Bond Bioisosteres: Strategies, Synthesis and Successes.

  2020cites this paper
• Applications of amide isosteres in medicinal chemistry.

  2019cites this paper
• Novel stable analogues of the neurotensin C-terminal hexapeptide containing unnatural amino acids

  2019cites this paper
• Highly Enantioselective Synthesis of Functionalized Glutarimide Using Oxidative N-Heterocyclic Carbene Catalysis: A Formal Synthesis of (-)-Paroxetine.

  2019cites this paper
• Pharmacophore Structure Based Protein Modelling for Factor VIII via the Implication of Computational Tools.

  2018cites this paper
• Introduction to Mid-size Drugs and Peptidomimetics

  2018cites this paper
• Catalytic enantioselective synthesis of α-chiral azides

  2018cites this paper
• Drug discovery: Standing on the shoulders of giants

  2017cites this paper
• Novel Aryl Boronate Ester Based Amino Acids as Orthogonal Building Blocks for Fmoc Solid Phase Peptide Synthesis

  2017cites this paper
• Catalytic Michael/Ring-Closure Reaction of α,β-Unsaturated Pyrazoleamides with Amidomalonates: Asymmetric Synthesis of (-)-Paroxetine.

  2016cites this paper
• Shrimp (Pandalopsis dispar) waste hydrolysate as a source of novel β–secretase inhibitors

  2016cites this paper
• Characteristics of allosterism in drug action

  2016cites this paper
• Highly stable atropisomers by electrophilic amination of a chiral γ-lactam within the synthesis of an elusive conformationally restricted analogue of α-methylhomoserine

  2016cites this paper
• A signal-on electrochemical strategy for protease detection based on the formation of ATCUN-Cu(II)

  2016cites this paper
• Synthesis of Constrained Peptidomimetics via the Pictet-Spengler Reaction

  2016cites this paper
• Efficient synthesis of Xaa-Gly type (Z)-chloroalkene dipeptide isosteres via organocuprate mediated reduction

  2016cites this paper
• INSIGHTS INTO THE MOLECULAR DOCKING STUDY OF WEDELOLACTONE TO IMPROVE THE PERFORMANCE OF COMPUTER-AIDED DRUG DESIGN

  2016cites this paper
• Stereoselective synthesis of 1,2-diamine containing indolines by a conjugate addition nitro-Mannich reaction.

  2015cites this paper
• MMP Inhibitors: Past, present and future.

  2015cites this paper
• Formal [4+1] annulation reactions in the synthesis of carbocyclic and heterocyclic systems.

  2015cites this paper
• trans-(3S,4S)-Disubstituted pyrrolidines as inhibitors of the human aspartyl protease renin. Part I: prime site exploration using an amino linker.

  2015cites this paper
• Therapeutics Targeting Matrix Metalloproteinases

  2015cites this paper
• Characterization of β-secretase inhibitory peptide purified from skate skin protein hydrolysate

  2014influential citation
• Structure-based β-secretase (BACE1) inhibitors.

  2014cites this paper
• Conjugate addition nitro-Mannich reaction of carbon and heteroatom nucleophiles to nitroalkenes

  2014cites this paper
• Toward Tripeptidomimetic CXCR4 Antagonists: Design, Synthesis, Biological Evaluation, and Binding Mode Studies

  2014cites this paper
• Elements and modulation of functional dynamics.

  2014cites this paper
• An enantioselective tandem reduction/nitro-Mannich reaction of nitroalkenes using a simple thiourea organocatalyst

  2013cites this paper
• LIE : Method and Applications in Drug Design

  2013cites this paper
• Recent progress on the discovery of non-peptidic direct renin inhibitors for the clinical management of hypertension

  2013cites this paper
• Synthesis and docking of novel piperidine renin inhibitors

  2013cites this paper
• Synthesis of the reported structure of piperazirum using a nitro-Mannich reaction as the key stereochemical determining step

  2013cites this paper
• Amplified voltammetric characterization of cleavage of the biotinylated peptide by BACE1 and screening of BACE1 inhibitors.

  2013cites this paper
• Template-induced macrocycle diversity through large ring-forming alkylations of tryptophan.

  2013cites this paper
• Modular construction of quaternary hemiaminal-based inhibitor candidates and their in cellulo assessment with HIV-1 protease.

  2013cites this paper
• From peptides to peptidomimetics: rational design of potential PKC-β II inhibitors

  2013cites this paper
• Retrospective molecular docking study of WY-25105 ligand to β-secretase and bias of the three-dimensional structure flexibility

  2013cites this paper
• The discovery of novel potent trans-3,4-disubstituted pyrrolidine inhibitors of the human aspartic protease renin from in silico three-dimensional (3D) pharmacophore searches.

  2013cites this paper
• Why Enzymes as Drug Targets

  2013cites this paper
• A novel class of oral direct renin inhibitors: highly potent 3,5-disubstituted piperidines bearing a tricyclic p3-p1 pharmacophore.

  2013cites this paper
• The -BF-NH- link as a peptide-bond surrogate.

  2012cites this paper
• Convergent synthesis of aminomethylene peptidomimetics

  2012cites this paper
• Combining Dyad Protonation and Active Site Plasticity in BACE-1 Structure-Based Drug Design

  2012cites this paper
• Linear interaction energy: method and applications in drug design.

  2012cites this paper
• A new approach for investigating protein flexibility based on Constraint Logic Programming. The first application in the case of the estrogen receptor.

  2012cites this paper
• Organocatalytic sequential α-amination/Corey-Chaykovsky reaction of aldehydes: a high yield synthesis of 4-hydroxypyrazolidine derivatives.

  2012cites this paper
• Discovery and Development of Aliskiren, the First‐in‐Class Direct Renin Inhibitor for the Treatment of Hypertension

  2011cites this paper
• Minimalist and universal peptidomimetics.

  2011cites this paper
• Synthesis of tripeptide mimetics based on dihydroquinolinone and benzoxazinone scaffolds.

  2011cites this paper
• Desenvolvimento de um filtro de descritores moleculares geométricos para gerar um ranqueamento em Banco de Dados de ligantes

  2011cites this paper
• Design and synthesis of amidine-type peptide bond isosteres: application of nitrile oxide derivatives as active ester equivalents in peptide and peptidomimetics synthesis.

  2011cites this paper
• Computational Perspectives into Plasmepsins Structure—Function Relationship: Implications to Inhibitors Design

  2011cites this paper
• Nonpeptide BACE1 Inhibitors: Design and Synthesis

  2011cites this paper
• Universal peptidomimetics.

  2011cites this paper
• Direct detection of structurally resolved dynamics in a multiconformation receptor-ligand complex.

  2011cites this paper
• From “fluctuation fit” to “conformational selection”: Evolution, rediscovery, and integration of a concept

  2011cites this paper
• Mammalian and viral protease inhibitors

  2010cites this paper
• Discovery of cyclic acylguanidines as highly potent and selective beta-site amyloid cleaving enzyme (BACE) inhibitors: Part I--inhibitor design and validation.

  2010cites this paper
• Enantioselective Desymmetrization of meso-N-(Heteroarenesulfonyl)aziridines with TMSN3 Catalyzed by Chiral Lewis Acids.

  2010cites this paper
• Phytoecdysteroids and vitamin D analogues--similarities in structure and mode of action.

  2010cites this paper
• Emerging methods for ensemble-based virtual screening.

  2010cites this paper
• NXO building blocks for backbone modification of peptides and preparation of pseudopeptides.

  2010cites this paper
• Anticancer activity of N-bis(trifluoromethyl)alkyl-N'-(polychlorophenyl) and N'-(1,2,4-triazolyl) ureas.

  2010cites this paper
• Direct renin inhibitors as a new therapy for hypertension.

  2010cites this paper
• Target validation and ligand development for a pathogenic fungal profilin, using a knock‐down strain of pathogenic yeast Candida glabrata and structure‐based ligand design

  2010cites this paper
• Computer-aided drug-discovery techniques that account for receptor flexibility.

  2010cites this paper
• Peptides as Molecular Receptors

  2010cites this paper
• Discovery of Inhibitors of Protein–Protein Interactions by Screening Chemical Libraries

  2010cites this paper
• Synthesis of a new family of 2-ethylidene-γ-unsaturated δ-amino esters via microwave activated Stille coupling

  2010cites this paper
• Enolate amination and derivatization of a pyrroloisoquinoline template: towards novel peptidomimetics

  2010cites this paper
• The role of dynamic conformational ensembles in biomolecular recognition.

  2009cites this paper
• Computational multiscale modeling in protein--ligand docking

  2009cites this paper
• Computational Multiscale Modeling in

  2009cites this paper
• 1,2,3-Triazole Fused Quinoline-Peptidomimetics: Studies on Synthesis, DNA Binding and Photonuclease Activity

  2009cites this paper
• Modeling Reality for Optimal Docking of Small Molecules to Biological Targets

  2009cites this paper
• Amino acid-based synthesis of trifluoromethylalkene dipeptide isosteres by alcohol-assisted nucleophilic trifluoromethylation and organozinc-copper-mediated S(N)2' alkylation.

  2009cites this paper
• The utility of molecular dynamics simulations for understanding site‐directed mutagenesis of glycine residues in biotin carboxylase

  2009cites this paper
• Stereoselective synthesis of anti-N-protected 3-amino-1,2-epoxides by nucleophilic addition to N-tert-butanesulfinyl imine of a glyceraldehyde synthon.

  2009cites this paper
• Fragment-based discovery of nonpeptidic BACE-1 inhibitors using tethering.

  2009cites this paper
• Comprehensive radiolabeling, stability, and tissue distribution studies of technetium-99m single amino acid chelates (SAAC).

  2009cites this paper
• How computational methods try to disclose the estrogen receptor secrecy--modeling the flexibility.

  2009cites this paper
• Novel Method for Probing the Specificity Binding Profile of Ligands: Applications to HIV Protease

  2008cites this paper
• Synthesis and conformational analysis of benzimidazole-based reverse turn mimics

  2008cites this paper
• Three-component synthesis of 1,4-diazepin-5-ones and the construction of gamma-turn-like peptidomimetic libraries.

  2008cites this paper
• Diversity-oriented synthesis of a drug-like system displaying the distinctive N-->C=O interaction.

  2008cites this paper
• Synthesis of Substituted 2‐Amino‐cyclobutanones

  2008cites this paper
• Efficient synthesis of trifluoromethyl and related trisubstituted alkene dipeptide isosteres by palladium-catalyzed carbonylation of amino acid derived allylic carbonates.

  2008cites this paper
• Diastereoselective synthesis of highly functionalized fluoroalkene dipeptide isosteres and its application to Fmoc-based solid-phase synthesis of a cyclic pentapeptide mimetic

  2008cites this paper
• Chapter 35 – 1α,25(OH)2 Vitamin D3Vitamin D Nuclear Receptor (VDR) and Plasma Vitamin D-Binding Protein (DBP) Structures and Ligand Shape Preferences for Genomic and Rapid Biological Responses

  2008cites this paper
• Cis‐Configured Aziridines Are New Pseudo‐Irreversible Dual‐Mode Inhibitors of Candida albicans Secreted Aspartic Protease 2

  2008cites this paper
• Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go

  2008cites this paper
• Straightforward Synthesis of α‐Substituted Prolines by Cross‐Metathesis

  2008cites this paper
• Recent advances in the discovery of non-peptidic direct renin inhibitors as antihypertensives: new patent applications in years 2000 – 2008

  2008cites this paper